|
Delayed
Berne S.E.
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | - |
Business description: Catalent, Inc.
- provision of development services and clinical supply services (62.2%);
- subcontracted manufacturing services (37.8%).
Net sales are distributed geographically as follows: the United States (62.7%), Europe (30.6%) and other (6.7%).
Sales by Activity: Catalent, Inc.
| Fiscal Period: June | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) |
|---|---|---|---|---|---|
Pharma and Consumer Health | - | - | - | 2.29B | 2.43B |
Softgel and Oral Technologies | 1.06B | 1.01B | 1.25B | - | - |
Clinical Supply Services | 345M | 391M | 400M | - | - |
Biologics | 1.02B | 1.93B | 2.55B | 1.98B | 1.95B |
Inter-Segment Revenue Elimination | -10.2M | -19M | -17M | -2M | -2M |
Oral and Specialty Delivery | 676M | 686M | 650M | - | - |
Geographical breakdown of sales: Catalent, Inc.
| Fiscal Period: June | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) |
|---|---|---|---|---|---|
United States | 1.82B | 2.46B | 3.11B | 2.77B | 2.82B |
Europe | 976M | 1.34B | 1.51B | 1.26B | 1.36B |
Other | 376M | 288M | 327M | 355M | 356M |
Elimination of Revenue Attributable to Multiple Locations | -79.8M | -95M | -115M | -117M | -157M |
Executive Committee: Catalent, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 2022-06-30 | |
Matti Masanovich
DFI | Director of Finance/CFO | 54 | 2023-07-04 |
Tom Hawkeswood
COO | Chief Operating Officer | - | 2025-08-31 |
Joseph Ferraro
CMP | Compliance Officer | 49 | 2023-02-12 |
Lim Chin Wei
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
Composition of the Board of Directors: Catalent, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 2022-06-30 | |
Timothy Walbert
BRD | Director/Board Member | 59 | - |
Jonathan L. Levy
BRD | Director/Board Member | - | - |
Susan Mahony
BRD | Director/Board Member | 61 | - |
Charles Patten
BRD | Director/Board Member | - | - |
| Director/Board Member | 55 | - |
Company details: Catalent, Inc.
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CTLT Stock
- 0C8 Stock
- Company Catalent, Inc.
Select your edition
All financial news and data tailored to specific country editions
